Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -6523.04% is 166% below its 5-year average of -2453.32%, around the middle of its 5-year range (-14983.53%–51.61%).
14.06% below its 12-month average of -5718.81%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3782.43%.
NET PROFIT MARGIN
-6523.04%
NET PROFIT MARGIN AVG TTM
-5718.81%
NET PROFIT MARGIN AVG 3Y
-3885.78%
NET PROFIT MARGIN AVG 5Y
-2453.32%
NET PROFIT MARGIN AVG 10Y
-3634.83%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-14.06%
CURRENT VS 3Y AVG
-67.87%
CURRENT VS 5Y AVG
-165.89%
CURRENT VS 10Y AVG
-79.46%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-2508761.54%
vs the sector median at left
Co-Diagnostics, Inc.
Market Cap
$7.07M
Net Profit Margin
-6523.04%
TTM Avg
-5718.81%
3Y Avg
-3885.78%
5Y Avg
-2453.32%
Market Cap
$6.99M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-287.91%
5Y Avg
-676.70%
Market Cap
$7.18M
Net Profit Margin
-1977.59%
TTM Avg
-1280.67%
3Y Avg
-1780.71%
5Y Avg
-1415.68%
Market Cap
$7.25M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.89M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-19.45%
5Y Avg
-19.45%
Market Cap
$7.29M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.87M
Net Profit Margin
-611.47%
TTM Avg
-627.26%
3Y Avg
-917.71%
5Y Avg
-6297.45%
Market Cap
$7.36M
Net Profit Margin
-0.61%
TTM Avg
-82.77%
3Y Avg
-131.16%
5Y Avg
-372.00%
Market Cap
$6.82M
Net Profit Margin
0.00%
TTM Avg
-970.10%
3Y Avg
-487.29%
5Y Avg
1862.33%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Co-Diagnostics, Inc. (CODX) | $7.07M | -6523.04% | -5718.81% | -3885.78% | -2453.32% |
| KALA BIO, Inc. (KALA)vs › | $6.99M | 0.00% | 0.00% | -287.91% | -676.70% |
| Longeveron Inc. (LGVN)vs › | $7.18M | -1977.59% | -1280.67% | -1780.71% | -1415.68% |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $6.89M | 0.00% | 0.00% | -19.45% | -19.45% |
| Skye Bioscience, Inc. (SKYE)vs › | $7.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.87M | -611.47% | -627.26% | -917.71% | -6297.45% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.36M | -0.61% | -82.77% | -131.16% | -372.00% |
| Exicure, Inc. (XCUR)vs › | $6.82M | 0.00% | -970.10% | -487.29% | 1862.33% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.76M | -1084.23% | 0.00% | 0.00% | 0.00% |
Operating Margin
-5025.5%
Net Profit Margin
-6523.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -3782.43% |
| 2026-03-31 | -6262.27% |
| 2025-12-31 | -9755.05% |
| 2025-09-30 | -4049.27% |
| 2025-06-30 | -4745.02% |
| 2025-03-31 | -14983.53% |
| 2024-12-31 | -7387.37% |
| 2024-09-30 | -1512.37% |
| 2024-06-30 | -286.03% |
| 2024-03-31 | -3684.36% |
| 2023-12-31 | -412.82% |
| 2023-09-30 | -243.47% |
| 2023-06-30 | -4508.87% |
| 2023-03-31 | -956.11% |
| 2022-12-31 | -1563.02% |
| 2022-09-30 | -26.72% |
| 2022-06-30 | -53.48% |
| 2022-03-31 | 51.61% |
| 2021-12-31 | 36.75% |
| 2021-09-30 | 38.12% |
| 2021-06-30 | 35.77% |
| 2021-03-31 | 39.45% |
| 2020-12-31 | 47.18% |
| 2020-09-30 | 72.10% |
| 2020-06-30 | 62.42% |
| 2020-03-31 | -68.79% |
| 2019-12-31 | -1598.11% |
| 2019-09-30 | -4218.19% |
| 2019-06-30 | -2183.38% |
| 2019-03-31 | -40246.74% |
| 2018-12-31 | -18000.26% |
| 2018-09-30 | -16926.00% |
| 2018-06-30 | -14151.99% |
| 2018-03-31 | -13513.13% |
| 2017-12-31 | -57928.25% |
| 2017-09-30 | -149865.55% |
| 2017-06-30 | -34671.82% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | -5108.49% |
| 2015-12-31 | -4848.25% |
